0001140361-15-045632.txt : 20151228 0001140361-15-045632.hdr.sgml : 20151225 20151228111659 ACCESSION NUMBER: 0001140361-15-045632 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151222 FILED AS OF DATE: 20151228 DATE AS OF CHANGE: 20151228 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioRestorative Therapies, Inc. CENTRAL INDEX KEY: 0001505497 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 911835664 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: (631) 760-8100 MAIL ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: Stem Cell Assurance, Inc. DATE OF NAME CHANGE: 20101110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weinreb Mark CENTRAL INDEX KEY: 0001527212 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37603 FILM NUMBER: 151308293 MAIL ADDRESS: STREET 1: STEM CELL ASSURANCE, INC. STREET 2: 555 HERITAGE DRIVE CITY: JUPITER STATE: FL ZIP: 33458 4 1 doc1.xml FORM 4 X0306 4 2015-12-22 0 0001505497 BioRestorative Therapies, Inc. BRTX 0001527212 Weinreb Mark 40 MARCUS DRIVE MELVILLE NY 11747 1 1 1 0 CEO and Chairman of the Board Common Stock 85000 D Stock Option 10 2010-12-15 2020-12-14 Common Stock 4000 4000 D Stock Option 21 2022-02-09 Common Stock 50000 50000 D Stock Option 30 2022-12-07 Common Stock 20000 20000 D Stock Option 12 2023-10-04 Common Stock 12500 12500 D Stock Option 13 2024-02-18 Common Stock 50000 50000 D Stock Option 6.6 2024-10-23 Common Stock 150000 150000 D Option 7 2015-12-22 4 A 0 208000 0 A 2025-09-04 Common Stock 208000 208000 D The option is exercisable to the extent of 16,667 shares on each of February 10, 2012 and February 10, 2013 and 16,666 shares on February 10, 2014. The option is exercisable to the extent of 10,000 shares on each of December 7, 2012 and December 7, 2013. The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014. The option is exercisable to the extent of 16,667 shares on each of February 18, 2014 and February 18, 2015 and 16,666 shares on February 18, 2016. The option is exercisable to the extent of 50,000 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017. On December 22, 2015, the stockholders of the Issuer approved amendments to the Issuer's 2010 Equity Participation Plan (the "Plan") to increase the number of shares authorized to be issued pursuant to the Plan to 2,250,000. The Reporting Person had been granted the option on September 4, 2015, subject to stockholder approval of such amendments. The option is exercisable to the extent of 104,000 shares on December 22, 2015, 34,667 shares on each of September 4, 2016 and September 4, 2017, and 34,666 shares on September 4, 2018. /s/ Mark Weinreb 2015-12-22